华泰柏瑞生物医药混合A(004905)资产负债表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
资产 |
银行存款 |
- |
- |
- |
103,209,630.70 |
结算备付金 |
1,408,963.22 |
1,309,929.40 |
527,579.28 |
306,366.10 |
存出保证金 |
222,496.70 |
191,687.67 |
154,493.41 |
152,084.22 |
交易性金融资产 |
427,361,580.24 |
427,415,651.82 |
367,377,532.04 |
385,619,945.64 |
其中:股票投资 |
427,361,580.24 |
427,415,651.82 |
367,377,532.04 |
385,619,945.64 |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
3,877,167.60 |
- |
- |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
112,754.17 |
192,540.65 |
124,321.17 |
172,541.54 |
其他资产 |
- |
- |
- |
- |
资产总计 |
467,058,767.20 |
499,920,061.69 |
453,163,148.43 |
489,460,568.20 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
3,278,555.26 |
1,051,238.13 |
6,197,472.80 |
8,777,330.80 |
应付赎回款 |
1,061,146.11 |
225,555.90 |
520,473.22 |
311,035.04 |
应付管理人报酬 |
484,710.96 |
480,681.40 |
455,579.92 |
604,041.67 |
应付托管费 |
80,785.15 |
80,113.59 |
75,930.01 |
100,673.59 |
应付销售服务费 |
44,589.84 |
27,671.65 |
14,358.46 |
14,968.20 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
685,205.69 |
1,245,046.30 |
695,876.61 |
541,968.49 |
负债合计 |
5,634,993.01 |
3,110,306.97 |
7,959,691.02 |
10,350,017.79 |
所有者权益 |
实收基金 |
228,026,129.06 |
248,311,186.82 |
204,220,887.11 |
216,852,056.01 |
未分配利润 |
233,397,645.13 |
248,498,567.90 |
240,982,570.30 |
262,258,494.40 |
所有者权益合计 |
461,423,774.19 |
496,809,754.72 |
445,203,457.41 |
479,110,550.41 |
负债及所有者权益总计 |
467,058,767.20 |
499,920,061.69 |
453,163,148.43 |
489,460,568.20 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年